Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
89.94
-0.21 (-0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
63
64
Next >
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
September 18, 2023
From
BioNTech SE
Via
GlobeNewswire
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
September 15, 2023
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...
Via
Benzinga
Exposures
COVID-19
Product Safety
BioNTech Unusual Options Activity For August 30
August 30, 2023
Via
Benzinga
Expert Ratings for BioNTech
August 28, 2023
Via
Benzinga
BioNTech Unusual Options Activity For August 21
August 21, 2023
Via
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
September 14, 2023
Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now.
Via
InvestorPlace
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood'
September 13, 2023
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.
Via
Investor's Business Daily
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
September 12, 2023
Benzinga
Via
Benzinga
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
The U.S.
Via
Benzinga
Exposures
COVID-19
Product Safety
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
September 11, 2023
From
Pfizer Inc.
Via
Business Wire
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry
September 06, 2023
On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the...
Via
Benzinga
Exposures
COVID-19
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant
September 06, 2023
Pirola has about 30 mutations compared with previous omicron versions of the virus.
Via
Investor's Business Daily
Exposures
COVID-19
3 Stocks to Buy For the COVID Resurgence
September 06, 2023
The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting
Via
MarketBeat
Exposures
COVID-19
Product Safety
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...
Via
Benzinga
Exposures
COVID-19
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
September 02, 2023
Shanghai GenFleet Technologies partnered three preclinical small-molecule candidates for RAS pathway-driven cancers to Verastem Oncology in a deal that could be worth up to $625.5 million. GenFleet...
Via
Talk Markets
Jeff Bezos Vs. Elon Musk Space Contract Lawsuit, Novo Nordisk's Famed Drug Ozempic Could Be Next Contender For Medicare Negotiations, Tesla Rival XPeng's August Deliveries Zooms 43%: Today's Top Stories
September 01, 2023
Tech Crunch
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns
September 01, 2023
The European Commission has approved Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech SE (NASDAQ:
Via
Benzinga
Exposures
COVID-19
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
August 30, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
August 30, 2023
From
BioNTech SE
Via
GlobeNewswire
Why Novavax Stock Was So Healthy on Monday
August 28, 2023
As the coronavirus threat rises, so too does the vaccine maker's value to investors.
Via
The Motley Fool
Exposures
COVID-19
Why BioNTech Shares Are Rising During Monday's Session
August 28, 2023
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by some 2.25% to $120.26 Monday. The stock is gaining today amid rising COVID-19 cases in the U.S.
Via
Benzinga
Exposures
COVID-19
5 Value Stocks To Watch In The Healthcare Sector
August 28, 2023
Via
Benzinga
COVID Is Making a Comeback: Should You Buy These 2 Stocks?
August 27, 2023
Can these companies keep up their recent momentum?
Via
The Motley Fool
Exposures
COVID-19
Novavax (NVAX) Stock Is Getting Ready to Rally Again
August 22, 2023
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.
Via
InvestorPlace
Exposures
COVID-19
Why Moderna, BioNTech SE, and Novavax Surged Today
August 21, 2023
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign.
Via
The Motley Fool
Exposures
COVID-19
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.
Via
Benzinga
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday
August 21, 2023
U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance
August 18, 2023
The companies are hoping to launch their updated Covid shots in September.
Via
Investor's Business Daily
Exposures
COVID-19
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
August 18, 2023
Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
63
64
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.